Abstract
The expression of adhesion molecules on human tonsillar follicular dendritic cells (FDCs) in vivo on cryostat sections and in vitro on isolated FDCs on cytospin preparations was studied. Isolation of FDCs was performed using a magnetic cell sorter (MACS). Immunochemically, FDCs were positive for Mac-1 (CD11b), sialyl-Lex (CD15s), CD22, integrin β1 (CD29), CD40, VLA-α3 (CD49c), VLA-α5 (CD49e), VLA-α6 (CD49f), ICAM-3 (CD50), ICAM-1 (CD54), B7 (CD80), and VCAM-1 (CD106). These adhesion molecules, except ICAM-3 (CD50) which was weakly positive only in the light zone (LZ), were positive with a lacy pattern in all zones of secondary lymphoid follicle, especially strong in the LZ. ICAM-3 (CD50) was positive on more than half of isolated FDCs, but other molecules were positive on almost all isolated FDCs. Concerning the ligands on B cells for these adhesion molecules, the Mac-1 (CD11b)-ICAM-1 (CD54), the ICAM-3 (CD50)-LFA-1 (CD11a/18), and the VCAM-1 (CD106)-VLA-4 (CD29/49d) interactions in the LZ, the sialy-Lex (CD15s)-L-selectin (CD62L) and the VCAM-1 (CD106)-VLA-4 (CD29/49d) interactions in the mantle zone, and the ICAM-1 (CD54)-LFA-1 (CD11a/18) interaction in the entire lymphoid follicle may participate in FDC-B cell adhesion. Furthermore, above mentioned immunohistochemical evidence that FDCs were positive for fibronectin-receptor (CD29/CD49e) and laminin-receptor (CD29/CD49f), was confirmed with a frozen-section binding assay, using isolated FDCs and cryostat sections of tonsils. The numbers of FDCs binding to germinal centers (GCs) were reduced remarkably by pretreatment with monoclonal antibodies for CD29 (32.8±4.1% of the control), CD49e (29.7±2.5%), and CD49f (18.8±0.8%). These data clearly indicated that FDCs bind to the reticulin or laminin fiber in GCs via either receptor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the Japan Society of the Reticuloendothelial System
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.